These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Kava: a comprehensive review of efficacy, safety, and psychopharmacology. Sarris J; LaPorte E; Schweitzer I Aust N Z J Psychiatry; 2011 Jan; 45(1):27-35. PubMed ID: 21073405 [TBL] [Abstract][Full Text] [Related]
5. Herbal medicines in Hawaii from tradition to convention. Norton SA Hawaii Med J; 1998 Jan; 57(1):382-6. PubMed ID: 9509742 [TBL] [Abstract][Full Text] [Related]
6. [Treatment with Kava--the root to ocombat stress]. Müller B; Komorek R Wien Med Wochenschr; 1999; 149(8-10):197-201. PubMed ID: 10483680 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.). Anke J; Ramzan I J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747 [TBL] [Abstract][Full Text] [Related]
13. Kava and alcohol. Cantor C Med J Aust; 1997 Nov; 167(10):560. PubMed ID: 9397054 [No Abstract] [Full Text] [Related]
14. Effect of kava in normal subjects and patients. Pfeiffer CC; Murphree HB; Goldstein L Psychopharmacol Bull; 1967 Dec; 4(3):12. PubMed ID: 5615543 [No Abstract] [Full Text] [Related]
15. The correlation between cancer incidence and kava consumption. Steiner GG Hawaii Med J; 2000 Nov; 59(11):420-2. PubMed ID: 11149250 [TBL] [Abstract][Full Text] [Related]
16. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro. Weiss J; Sauer A; Frank A; Unger M Drug Metab Dispos; 2005 Nov; 33(11):1580-3. PubMed ID: 16051732 [TBL] [Abstract][Full Text] [Related]
17. Kava, the anxiolytic herb: back to basics to prevent liver injury? Teschke R; Sarris J; Glass X; Schulze J Br J Clin Pharmacol; 2011 Mar; 71(3):445-8. PubMed ID: 21284704 [TBL] [Abstract][Full Text] [Related]